BioVoice eMagazine April 2025 | Issue 4 | Volume 6
COVER STORY
INDIA’S NEXT BIOPHARMA BOOM
Biosimilars industry eyes a billion-dollar windfall
The biopharmaceutical industry is entering a significant transformation phase as numerous blockbuster biologic drugs approach their patent expiration globally. This transition opens up vast opportunities for countries with strong pharmaceutical capabilities, and India stands to benefit immensely. We explore the scale of the patent expiry wave, its implications for the global market, and how the Indian pharmaceutical industry can position itself as a dominant player in the biosimilars and biopharma space.
INTERVIEW
“Patent expiry of significant number of biologics by 2030 is a huge opportunities for biosimilars players ”
In an exclusive interview, Dr Cyrus Karkaria, President-Biotechnology, Lupin Limited shares his views on the current market trends and growth prospects of Indian biosimilars industry, company’s key offerings, ongoing initiatives, and future plans.
INTERVIEW
“Biomanufacturing has shifted focus from just being efficient to staying ahead of the curve”
In an exclusive interview, Sachin Joshi, Managing Director & Founder, PharmNXT Biotech shares insights on the company’s focus on innovation, key product offerings, upcoming initiatives, sustainability and future plans.
INTERVIEW
“Medtronic’s $60 million investment in Hyderabad will create 300 job opportunities”
In an exclusive interview, Mandeep Singh Kumar, Managing Director and Vice President, Medtronic India shares details on the company’s key milestones, its key offerings, upcoming initiatives, and future plans.
INTERVIEW
“We will invest Rs 400 crore to establish bio-fertilizer & bio-pesticide production facility in Gujarat”
In an exclusive interview, Harshvardhan Bhagchandka, President, IPL Biologicals shares details on the company’s journey so far, its unique key offerings, big ticket projects, and future plans
The post BioVoice eMagazine April 2025 | Issue 4 | Volume 6 appeared first on BioVoiceNews.
News